Liraglutide obesity drug molecule

Liraglutide obesity drug molecule

C028/8037 Rights Managed

Request low-res file

530 pixels on longest edge, unwatermarked

Request/Download high-res file

Uncompressed file size: 50.1MB

Downloadable file size: 2.7MB

Price image Pricing

Please login to use the price calculator


Credit: DR TIM EVANS/SCIENCE PHOTO LIBRARY

Caption: Liraglutide. Molecular model of the drug Liraglutide, used to treat obesity and diabetes. This is a long-acting glucagon-like peptide-1 receptor agonist which binds to the same receptors as does the body's GLP-1 hormone. It stimulates insulin secretion which controls blood sugar levels, decreases the production of the hormone glucagon, slows gastric emptying, and reduces appetite. It is used for the management of type 2 diabetes under the trade name Victoza, and as a treatment for obesity in adults under the name Saxenda. Atoms are represented as spheres and are colour-coded: carbon (light blue), hydrogen (white), nitrogen (dark blue), oxygen (red).

Release details: Model release not required. Property release not required.

Keywords: anorectic, anti-obesity, appetite, artwork, biochemical, biochemistry, biological, biology, black background, blood glucose, chemical, chemistry, cut out, cut outs, cut-out, cut-outs, cutout, cutouts, diabetes, diet, digitally generated, drug, fat, glp, glp-1, glucagon-like peptide, healthcare, hormone, hyperglycaemia, illustration, insulin, liraglutide, long-acting glucagon-like peptide-1 receptor agonist, medical, medicine, model, molecular, molecule, nn2211, no one, no-one, nobody, obesity, pharmaceutical, pharmaceutics, pharmacological, pharmacology, plain background, research, saxenda, slimming, space-fill, space-filled, spacefill, spacefilled, structure, suppressant, type 2 diabetes, victoza, weight, weight loss, weight-loss

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.